A brief community linkage intervention for veterans with a persistent mental illness and a co-occurring substance abuse disorder by Smelson, David A. et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Psychiatry Publications and Presentations Psychiatry 
2007-4 
A brief community linkage intervention for veterans with a 
persistent mental illness and a co-occurring substance abuse 
disorder 
David A. Smelson 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/psych_pp 
 Part of the Mental Disorders Commons, Psychiatry Commons, and the Substance Abuse and 
Addiction Commons 
Repository Citation 
Smelson DA, Losonczy MF, Ziedonis DM, Sussner BD, Castles-Fonseca K, Rodrigues S, Kline A. (2007). A 
brief community linkage intervention for veterans with a persistent mental illness and a co-occurring 
substance abuse disorder. Psychiatry Publications and Presentations. https://doi.org/10.4321/
S0213-61632007000200006. Retrieved from https://escholarship.umassmed.edu/psych_pp/641 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Psychiatry Publications 
and Presentations by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
Eur. J. Psychiat. Vol. 21, N.° 2, (143-152)
2007
Keywords: Psychosocial treatment, Schizophrenia,
Integrated treatment.
A brief community linkage intervention 
for veterans with a persistent mental illness 
and a co-occurring substance abuse disorder 
David A. Smelson, Psy.D.*,**,***
Miklos F. Losonczy, M.D., Ph.D.*,**,***
Douglas Ziedonis, M.D., M.P.H.**
Bradley D. Sussner, Ph.D.**
Kathy Castles-Fonseca, Psy.D.*
Stephanie Rodrigues, B.S.*
Anna Kline, Ph.D.**
* Department of Veterans Affairs, New Jersey
Health Care System
** Department of Psychiatry, University of
Medicine and Dentistry-Robert Wood
Johnson Medical School
*** Department of Psychiatry, University of
Medicine Dentistry-New Jersey Medical
School-Newark
USA
ABSTRACT – Objective: Individuals with co-occurring psychiatric and substance abuse
problems often exhibit poor outpatient treatment engagement and re-hospitalization fol-
lowing discharge from acute psychiatric services. Although case management can
improve treatment engagement and reduce attrition, these services are often delivered
indefinitely, limiting the availability of treatment slots. In an effort to reduce re-hospital-
ization rates and improve outcomes during the transition from inpatient to outpatient treat-
ment, we developed and evaluated Time-Limited Case Management (TLC), an eight-week
integrated mental health and substance abuse augmentation intervention. 
Method: Sixty-five dually diagnosed veterans admitted to inpatient psychiatric treat-
ment were included in the program evaluation, 32 who received the TLC service in addition
to Treatment as Usual (TAU) that began during inpatient treatment and continued after the
transition to outpatient services, and a comparison group of 33 who received only TAU
without transitional support provided through the TLC augmentation service. 
Results: The TLC group had fewer days and episodes of hospitalization at two and six
month post-study entry. Furthermore, the TLC group exhibited greater improvements on
the Global Assessment of Functioning from baseline to the six-month follow-up. 
Conclusion: TLC appears to be an effective transitional augmentation service with
benefits that persist beyond the eight weeks of the program. Future research should
Background and Objectives
Individuals with co-occurring mental ill-
ness and substance abuse problem are often
non-adherent with treatment and have diffi-
culty engaging in outpatient care. Studies
have reported attrition rates of up to 36% dur-
ing the transition from inpatient to outpatient
treatment1. Dropout rates following the initia-
tion of treatment are as alarmingly high and
often above 70%, which compromised the
success of the sophisticated integrated thera-
pies that have been developed to meet the
unique needs of the individuals with a co-
occurring disorder2,3. Case management aug-
mentation interventions have been used to
assist with engaging this population in inte-
grated co-occurring disorders treatment pro-
grams, but tend to be based on long-term case
management models that often leave mental
health systems with far fewer available treat-
ment slots than needed4,5. 
In response to the large demand for case
management services, the field has recently
begun to examine time-limited interventions
that specifically target vulnerable periods
during recovery from psychiatric and sub-
stance abuse problems. Several of these new
approaches have the potential to reduce the
cost and use of acute services, to improve
psychosocial and substance abuse outcomes,
and to increase linkages with primary care
providers6,7. It appears that the critical ele-
ment to successful outcomes for time-limited
case management interventions is the con-
nection to community-based treatment ser-
vices, rather than indefinite case manage-
ment services8. 
Recognizing that the transition from
inpatient psychiatric care to outpatient treat-
ment is often a vulnerable period for people
with co-occurring disorders, we developed
and evaluated “Time-Limited Case Manage-
ment” (TLC), an eight-week linkage inter-
vention that combines short-term case man-
agement, integrated substance abuse and
mental health treatment, and peer support.
The TLC approach is consistent with the
recommendations included in the Substance
Abuse and Mental Health Services Adminis-
tration (SAMHSA) 2002 report to Congress9
and the President’s New Freedom Commis-
sion on Mental Health report10, both of
which are critical reports in the United
States aimed at improving the fragmented
health care system; these reports highlight
the need for integrated and coordinated dual
diagnosis services. This paper describes the
eight-week approach and reports on a pre-
liminary evaluation of its effectiveness. 
Methods
Subjects
Sixty-five individuals with co-occurring
mental illness and substance abuse disor-
ders treated on the Acute Psychiatry unit of
the Department of Veterans Affairs New Jer-
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sey Health Care System were included in
the project. Thirty-two individuals received
the TLC augmentation intervention in addi-
tion to treatment as usual (TAU) that con-
sisted of treatment on the Acute Psychiatry
unit and a referral for intensive outpatient
mental health and substance abuse treat-
ment. A comparison group of thirty-three
individuals received only TAU. All of the
individuals included in this trial were diag-
nosed by a doctoral level clinical psycholo-
gist (KCF). Subjects for both groups were
included if they1: met DSM-IV diagnostic
criteria for schizophrenia, schizoaffective
disorder, bipolar I disorder or major depres-
sive disorder, and co-occurring substance
dependence2; had a permanent or transition-
al residence11; were willing and able to use
public transportation. Subjects were exclud-
ed from the study if they met any of the fol-
lowing criteria:1 did not have a chronic
mental illness as described above, including
substance-induced psychiatric disorder2;
were homeless; or11 had significant medical
problems that prevented ambulation. 
Because the primary objective of the pro-
ject was to develop a new treatment inter-
vention, resources were only available to
conduct a modest program evaluation rather
than a rigorous, randomized controlled
research study. Therefore, we used a natu-
ralistic design that included a non-random-
ized convenience sample who did not sign
an informed consent. We later received
Institutional Review Board approval to
extract demographic, service utilization,
and clinical outcome data from the entire
sample and to publish the findings. 
Treatment as Usual (TAU) 
All subjects in both groups received TAU
on the inpatient psychiatric unit followed by
a referral to outpatient treatment. Both the
inpatient and outpatient programs of the VA
New Jersey Health Care System offer psycho-
educational skills training, medication man-
agement and relapse prevention approaches.
Treatment services are primarily delivered in
a group format, although patients also partici-
pate in individual therapy sessions as needed
on the inpatient unit and several times a
month during outpatient treatment. The aver-
age length of stay on the inpatient psychiatric
unit in the fiscal year that the TLC program
was developed and evaluated was 13 days.
Veterans enrolled in outpatient care are gen-
erally in attendance for three days per week
for approximately one year. 
TLC Treatment 
The TLC augmentation intervention con-
sisted of a comprehensive and integrated set
of treatment approaches that include a mod-
ified version of Dual Recovery Therapy
(DRT), Critical Time Intervention case
management (CTI), and peer support, which
are discussed below, to meet the diverse
needs of patients with co-morbid psychi-
atric and substance abuse problems. The
TLC approach was designed to augment
standard inpatient and outpatient treatment.
In an effort to increase continuity of care
across settings, TLC was delivered for 2
weeks during the patient’s stay in Acute
Psychiatry and for 6 weeks after their transi-
tion to outpatient care. A more detailed
description of each component of the inter-
vention is included in Figure 1. Because of
the structured and concrete nature of the
TLC services, Bachelor’s and Master’s level
clinicians deliver the DRT and CTI inter-
ventions with trained consumers doing the
peer support. A Doctoral level psychologists
performed the diagnostic assessments and
assist with the care coordination across
inpatient and outpatient treatment.
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Dual Recovery Therapy
DRT was originally designed as a twenty-
week manual-driven approach for treating
individuals with co-occurring psychiatric
and substance abuse disorders. The interven-
tion blends relapse prevention, social skills
training, motivational enhancement therapy,
and the “recovery language” of Twelve-Step
Therapy12,13. In a number of trials, DRT has
contributed to significant improvements in
psychiatric and substance abuse outcomes
and to better treatment adherence12,14. The
DRT approach was not modified from the
original format for the first six weeks of the
TLC intervention. This segment of DRT
emphasized motivational enhancement tech-
niques that promote treatment engagement
and compliance to minimize the recidivism
common among people with co-morbid dis-
orders12,14. The remaining two weeks of the
eight-week DRT component delivered
through TLC is modified from the original
format and focused on relapse prevention
techniques and psycho-educational skills. 
Critical Time Intervention Case
Management
The TLC intervention also included one
weekly case management session using the
Critical Time Intervention approach15. This
session involved assertive outreach, crisis
intervention, transportation assistance, money
management, housing assistance and referrals
to community programs. On the inpatient
psychiatric unit, the two case management
sessions (one shortly after arrival on the
unit-when ever possible within 72 hours
after admission and one prior to discharge)
served to assist with the development of a
treatment plan and to prepare the individual
for the transition to the community. 
Peer Support 
TLC also enlisted Peer Support Special-
ists who were in recovery from co-occurring
psychiatric and substance abuse disorders to
run two one-hour weekly support group
during the six-week outpatient phase. Peer
support was included in TLC due to the doc-
umented benefits of the intervention in
improving social functioning, increasing the
use of problem-centered coping strategies,
increasing treatment compliance, and reduc-
ing rates of re-hospitalization among dually
diagnosed patients16,17. The peer groups
were structured and always began with par-
ticipants self-monitor craving levels and
triggers, except for the first week orienta-
tion session. The peers, however, played a
key role in the orientation to the treatment
programs at each level of care and served as
mentors and role models to the individuals
entering their recovery journey. 
Intervention Schedule
Those in the TLC group received treat-
ment as usual on the inpatient psychiatric
unit along with five extra hours of DRT, CTI
and Peer Support programming a week.
Upon discharge, these individuals received
standard outpatient mental health and sub-
stance abuse treatment along with two DRT
groups, one individual CTI session, and two
peer support session each week for six
weeks. The same case managers provided
TLC services on both the inpatient and out-
patient units to foster continuity across lev-
els of care. Case managers were responsible
for providing input into treatment plans and
for assisting with the execution of the treat-
ment goals during and after the transition
from inpatient treatment. Throughout the
eight weeks of the program, the TLC case
managers functioned as secondary providers
to the inpatient and outpatient staffs to rein-
force the idea that the purpose of TLC was
to assist with the transition from inpatient to
outpatient care, not to replace existing ser-
vices. By emphasizing a supportive, rather
than a leading role in patient care, the TLC
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program enabled the outpatient staff to easi-
ly assume the service coordination responsi-
bilities by the end of the eight-week treat-
ment period. 
Assessments 
Assessments were conducted at baseline
within approximately seventy-two hours
after admission to the inpatient psychiatric
unit, and at two months and six months after
study entry. Subjects completed the Addic-
tion Severity Index18 to determine drug use
and functioning in various life domains (e.g.,
criminal justice, family/social, employment)
during the 30 days prior to the assessment.
Because the study had a broad inclusion cri-
teria, patients were also administered the
Behavioral and Symptom Identification
Scale (BASIS-32), a 32 item self-report
questionnaire that has been validated and
found reliable in both inpatient and outpa-
tient settings19. The BASIS accommodates a
variety of diagnostic categories with sub-
scales that assess “relation to self/others,”
“Depression/Anxiety,” Daily Living/Role
Functioning,” Impulsive/Addictive Behav-
ior,” “Psychosis”19. This instrument mea-
sures the change in self-reported symptom
and problem difficulty over the course of
treatment. The Global Assessment of Func-
tioning (GAF)20 was used to measure gener-
al psychiatric functioning. The GAF is a
widely used instrument that is part of the
Diagnostic and Statistical Manual for psy-
chiatric Disorders 4th addition and a VA per-
formance measure. Service utilization data
was obtained through chart reviews in the
VA’s electronic medical record system. 
Statistical Analyses 
Student’s independent samples t-tests
were used to measure group baseline differ-
ences on age, pre-treatment hospitalization,
length of current hospitalization, addiction
severity, and psychiatric functioning. Repeat-
ed measures ANOVAs were used to compare
the groups on days and episodes of hospital-
ization in the two and six months before and
two and six months after study entry. Due to
the large difference in the percentage of
subjects in the TLC and comparison groups
that were available for the two-month post-
study entry assessment period (25.0% vs.
81.8%, respectively), between groups
analyses comparing scores on the clinical
outcome measures at baseline and at the
two-month follow-up were not performed.
We were, however, more successful in
locating subjects for the six-month follow-
up assessments. This allowed us to perform
repeated measures ANOVAs to compare the
change in the groups over time on the GAF,
the BASIS-32 subscales, and the ASI drug
use subscales.
Results
At baseline, there were no significant dif-
ferences between the TLC and TAU groups
in terms of age, substance use in the 30 days
prior to the assessment, GAF score and the
BASIS-32 subscales (see Table I). Individu-
als in the treatment group, however, were
hospitalized for more days in the two
months prior to completing the initial study
evaluation. 
Post-discharge outcomes indicated that
individuals who received the TLC service
exhibited greater reductions than the com-
parison group in the number of hospitaliza-
tion days in the two months after their cur-
rent hospitalization compared to the two
months before their admission, F(1, 58) =
12.8, p < .01. Greater reductions in hospital-
ization days for the TLC group were also
observed for the six months before and six
months after their current psychiatric admis-
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sion, F(1, 58) = 4.02, p = .05. In addition to
the reduction in hospitalization days, mem-
bers of the TLC group experienced a greater
reduction in the number of episodes of hospi-
talization from the two months before study
entry to the two months after study entry, F(1,
58) = 6.33, p = .02, as well as the six months
before entering the study to the six months
after study entry, F(1, 58) = 7.14, p = .01. 
Results from the GAF indicated that sub-
jects in the TLC group exhibited greater
improvement in global psychiatric function-
ing than the comparison group over the course
of the study, F(1, 39) = 4.1, p = .05. The inter-
actions of group by time for the subscales of
the BASIS-32 were not significant: “Relation
to Self and Others,” F(1, 33) = .9, p = .35,
“Depression/Anxiety,” F(1, 33) = .6, p = .45,
“Daily Living/Role Functioning,” F(1, 33) =
.9, p = .35, “Impulsive/Addictive Behavior,”
F(1, 33) = .16, p = .72, “Psychosis,” F(1, 33) =
.16, p = .70, and “Average,” F(1, 33) = 1.3, p =
.27. In terms of substance abuse outcomes, the
TLC group displayed a trend toward greater
reductions in cannabis use from the baseline
to the six-month follow up assessment than
the comparison group, F(1, 38) = 3.4, p = .07.
Differences in change for alcohol, F(1, 38) =
1.27, p = .27, cocaine, F(1, 38) = .96, p = .33,
and heroin use, F(1, 38) = .1, p = .74, were not
significant. 
Conclusions
The findings of this study support the
main objective that individuals who
received the eight-week TLC augmentation
community linkage intervention would have
fewer days and episodes of acute inpatient
psychiatric readmission during the eight
weeks of the TLC intervention than subjects
who were discharged as usual with a referral
to outpatient treatment without additional
support. With regard to clinical outcomes,
subjects in the TLC group exhibited greater
improvements on the GAF than the compar-
A BRIEF COMMUNITY LINKAGE INTERVENTION 149
Table I
Baseline Demographic and Clinical Comparisons.
TLC Treatment Comparison Group
Means ± SD at Baseline (N = 33) (N = 37)
Age 45.4 ± 6.6 45.7 ± 6.6
Global Assessment of Functioning 44.9 ± 8.4 45.0 ± 8.2
Hospital Days Current Admission 20.0 ± 18.6 16.0 ± 10.5
*Hospital Days 2 Months Pretreatment 21.9 ± 18.1 14.1 ± 11.3
Hospital Days 6 Months Pretreatment 40.7 ± 34.9 30.5 ± 36.0 
Alcohol Use 30 Days Pretreatment 5.9 ± 8.6 4.3 ± 7.5
Heroin Use 30 Days Pretreatment .7 ± 2.1 2.1 ± 6.6
Cocaine Use 30 Days Pretreatment 5.6 ± 7.7 4.3 ± 7.6
Cannabis Use 30 Days Pretreatment .1 ± .4 1.2 ± 4.3
Days Intoxicated 30 Days Pretreatment 4.1 ± 7.1 3.7 ± 7.0
BASIS-32 Relation to Self/Others 1.7 ± 1.2 2.0 ± 1.0
BASIS-32 Depression/Anxiety 2.0 ± 1.3 2.4 ± 1.1
BASIS-32 Daily Living/Role Functioning 1.7 ± .92 2.2 ± 1.1
BASIS-32 Impulsive/Addictive Behavior 1.4 ± 1.1 1.1 ± .9
BASIS-32 Psychosis 1.6 ± 1.1 1.4 ± 1.0
BASIS-32 Average 1.8 ± 1.1 1.9 ± .9
ison group. It should be pointed out, howev-
er, that while some researchers have
expressed concerns over the GAF’s reliabil-
ity as an outcome measure because it is a
unidimensional rating scale for assessing
functional outcome21, other research involv-
ing case management interventions suggest
that the GAF may be more sensitive to treat-
ment effects then measures involving symp-
tom severity since the latter is often an
unstable trait that is heavily influences by a
variety of day-to-day circumstances5. Those
in the TLC group also exhibited less
cannabis use than the comparison group at a
level that approached statistical significance.
The most encouraging finding of this
study was that the significantly greater reduc-
tion in hospitalization days and episodes was
still evident six months after study entry. This
finding is consistent with the work of Drake
et al.22, and others using long-term models,
but is in stark contrast to the findings of
Havassy, et al.23 who observed that inten-
sive and expanded brokerage case manage-
ment were largely ineffective for decreasing
hospitalizations among dually diagnosed
subjects. It is possible that TLC was suc-
cessful in reducing re-hospitalization
because the program’s staff directly
addressed the challenges associated with
co-morbid disorders through DRT in addi-
tion to offering case management services. 
Despite the fact that the TLC service
resulted in robust reductions in the use of
acute inpatient services, it had less of an
impact on psychiatric and substance abuse
outcomes. Although we found large
improvements in global psychiatric func-
tioning and some reduction in cannabis use
for the TLC group, we observed little
improvement on the subscales of the BASIS-
32 or reductions in alcohol and cocaine use.
This is consistent with the conclusions of
Holloway et al.24, who reported that of the
case management studies they reviewed a
majority failed to find statistically signifi-
cant improvements in symptomatology.
Though it is possible that our relatively
small sample size limited the statistical
power of the study, it is also plausible that
six months is an insufficient period of time
in which to expect psychiatric and substance
abuse problems to stabilize in dually diag-
nosed subjects. 
Although traditional case management
has helped individuals in the transition from
inpatient hospitalization to outpatient care,
TLC appears to offer several advantages for
this population. Unlike many traditional
case management programs that are offered
indefinitely, TLC is delivered for only eight
weeks. This limited time frame allows clini-
cians to meet the needs of a greater number
of individuals (approximately 8-10 new
clients every eight weeks). Granholm et al.11
recently observed that a brief (up to 24
weeks) intervention for dually-diagnosed
individuals can result in long-term reduc-
tions in hospital use. Our preliminary find-
ings suggest that extended treatment bene-
fits can be obtained from an intervention
one-third as long. The TLC approach also
emphasizes early and consistent relation-
ships with clinicians and peers that begin
during psychiatric hospitalization to foster a
smooth transition across different levels of
care. The on-going presence of TLC clini-
cians during and after psychiatric hospital-
ization can add a sense of familiarity to out-
patient care and minimize the anxiety often
associated with beginning a new form of
treatment in a new setting. Another impor-
tant element of the TLC model is that it
simultaneously addresses the challenges
associated with psychiatric and substance
abuse disorders based on the premise that
each set of problems has an impact on the
others25-28. Too often these problems are
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conceptualized and treated by separate
teams of clinicians resulting in service frag-
mentation29. 
Although we believe that the positive
results we observed were attributable to the
unique characteristics of the TLC augmenta-
tion service, a number of methodological
limitations were associated with the natural-
istic nature of the study. Because randomiza-
tion was not used to assign subjects into
treatment groups, it is possible that pre-
existing differences between the groups on
such issues as insight into the presence of
psychiatric and substance abuse disorders,
recognition of the need for treatment, and
motivation to address personal problems
may have contributed to the results that were
obtained. Furthermore, although a doctoral-
level psychologist assessed all of the indi-
viduals entering the TLC service, a struc-
tured diagnostic instrument would have been
beneficial to substantiate the diagnosis and
inclusion into the study. In order to address
these limitations, future research on TLC
should include a large randomized con-
trolled design matched for the additional
attention received by the TLC augmentation
services. Finally, the TLC intervention needs
to be implemented and studied outside of the
VA system to determine its efficacy in other
more diverse systems of healthcare. 
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